Androgen receptor inhibitor EPI-506
Term · Oncology and biomedicine · MLC-T-ONC-010077
An orally bioavailable, small molecule inhibitor of the N-terminal domain (NTD) of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR inhibitor EPI-506 specifically binds to the NTD of AR, thereby inhibiting both AR activation and the AR-mediated signaling pathway. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells.
| Identifier | MLC-T-ONC-010077 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AR inhibitor EPI-506 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010077",
"term": "Androgen receptor inhibitor EPI-506",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable, small molecule inhibitor of the N-terminal domain (NTD) of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR inhibitor EPI-506 specifically binds to the NTD of AR, thereby inhibiting both AR activation and the AR-mediated signaling pathway. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells.",
"synonyms": [
"AR inhibitor EPI-506"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/androgen-receptor-inhibitor-epi-506/"
}
Record 1,086 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.